Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone 8PE1G) SynExpress pL-Cy2-I17-B Engineered Tregs (CAT#: ITS-1224-CR285)

DatasheetDatasheet
Description
This product utilizes Engineered Tregs that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone 8PE1G). We employs the HBV (pL-Cy2-IL-17-BamHI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Delayed feedback for a robust and sustained response against cancers.
Host
human
Target
CCL2
Clone
8PE1G
Species Reactivity
human
Cell Source
Engineered Tregs
Sensor Gene
Cy2
Promoter
pL
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.95
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.